SELLAS Life Sciences Group (SLS) Gains from Investment Securities: 2011-2023
Historic Gains from Investment Securities for SELLAS Life Sciences Group (SLS) over the last 2 years, with Dec 2023 value amounting to $368,000.
- SELLAS Life Sciences Group's Gains from Investment Securities was N/A to $368,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.8 million, marking a year-over-year change of. This contributed to the annual value of $526,000 for FY2024, which is 42.93% up from last year.
- SELLAS Life Sciences Group's Gains from Investment Securities amounted to $368,000 in Q4 2023, which was down 18.04% from $449,000 recorded in Q1 2022.
- SELLAS Life Sciences Group's Gains from Investment Securities' 5-year high stood at $853,000 during Q2 2020, with a 5-year trough of $123,000 in Q1 2020.
- Over the past 2 years, SELLAS Life Sciences Group's median Gains from Investment Securities value was $408,500 (recorded in 2022), while the average stood at $408,500.